- Title
- Author Correction: Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure (Nature Communications, (2022), 13, 1, (4423), 10.1038/s41467-022-32162-x)
- Creators
- Liora S. Katz - Icahn School of Medicine at Mount SinaiGabriel Brill - Stony Brook UniversityPili Zhang - Icahn School of Medicine at Mount SinaiAnil Kumar - University of UtahSharon Baumel-Alterzon - Icahn School of Medicine at Mount SinaiLee B. Honig - Icahn School of Medicine at Mount SinaiNicolás Gómez-Banoy - Cornell UniversityEsra Karakose - Icahn School of Medicine at Mount SinaiMarius Tanase - Icahn School of Medicine at Mount SinaiLudivine Doridot - InsermAlexandra Alvarsson - Icahn School of Medicine at Mount SinaiBennett Davenport - University of Colorado Anschutz Medical CampusPeng Wang - Icahn School of Medicine at Mount SinaiLuca Lambertini - Icahn School of Medicine at Mount SinaiSarah A. Stanley - Icahn School of Medicine at Mount SinaiDirk Homann - Icahn School of Medicine at Mount SinaiAndrew F. Stewart - Icahn School of Medicine at Mount SinaiJames C. Lo - Cornell UniversityMark A. Herman - Duke Medical CenterAdolfo Garcia-Ocaña - Icahn School of Medicine at Mount SinaiDonald K. Scott - Icahn School of Medicine at Mount Sinai
- Publication Details
- Nature communications, Vol.13(1), 5681
- Academic Unit
- Miller School of Medicine; Diabetes Research Institute (DRI)
- Language
- English
- Resource Type
- Journal article
- PMID
- 36167859
- Record Identifier
- 991032796017302976
Journal article
Author Correction: Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure (Nature Communications, (2022), 13, 1, (4423), 10.1038/s41467-022-32162-x)
Nature communications, Vol.13(1), 5681
2022-12-01
PMID: 36167859
Metrics
1 Record Views